Aker BioMarine AS

Informe acción OB:AKBM

Capitalización de mercado: NOK 4.3b

Salud financiera de hoja de balance de Aker BioMarine

Salud financiera controles de criterios 5/6

Aker BioMarine tiene un patrimonio de accionistas total de $354.7M y una deuda total de $395.3M, lo que sitúa su ratio deuda-patrimonio en 111.4%. Sus activos y pasivos totales son $813.5M y $458.8M respectivamente. El BAIT de Aker BioMarine es de $9.6M, por lo que su ratio de cobertura de intereses es de 0.3. Tiene efectivo e inversiones a corto plazo que ascienden a $32.0M.

Información clave

51.3%

Ratio deuda-patrimonio

US$182.20m

Deuda

Ratio de cobertura de intereses0.08x
EfectivoUS$16.30m
PatrimonioUS$355.50m
Total pasivoUS$454.60m
Activos totalesUS$810.10m

Actualizaciones recientes sobre salud financiera

Recent updates

At kr102, Is It Time To Put Aker BioMarine AS (OB:AKBM) On Your Watch List?

Aug 20
At kr102, Is It Time To Put Aker BioMarine AS (OB:AKBM) On Your Watch List?

Optimistic Investors Push Aker BioMarine AS (OB:AKBM) Shares Up 25% But Growth Is Lacking

Jul 19
Optimistic Investors Push Aker BioMarine AS (OB:AKBM) Shares Up 25% But Growth Is Lacking

What Does The Future Hold For Aker BioMarine AS (OB:AKBM)? These Analysts Have Been Cutting Their Estimates

Jul 16
What Does The Future Hold For Aker BioMarine AS (OB:AKBM)? These Analysts Have Been Cutting Their Estimates

There Are Reasons To Feel Uneasy About Aker BioMarine's (OB:AKBM) Returns On Capital

Jul 11
There Are Reasons To Feel Uneasy About Aker BioMarine's (OB:AKBM) Returns On Capital

These 4 Measures Indicate That Aker BioMarine (OB:AKBM) Is Using Debt In A Risky Way

Jun 03
These 4 Measures Indicate That Aker BioMarine (OB:AKBM) Is Using Debt In A Risky Way

There's No Escaping Aker BioMarine AS' (OB:AKBM) Muted Revenues

Feb 15
There's No Escaping Aker BioMarine AS' (OB:AKBM) Muted Revenues

There Are Reasons To Feel Uneasy About Aker BioMarine's (OB:AKBM) Returns On Capital

Nov 06
There Are Reasons To Feel Uneasy About Aker BioMarine's (OB:AKBM) Returns On Capital

Estimating The Fair Value Of Aker BioMarine AS (OB:AKBM)

Sep 06
Estimating The Fair Value Of Aker BioMarine AS (OB:AKBM)

We Think You Should Be Aware Of Some Concerning Factors In Aker BioMarine's (OB:AKBM) Earnings

Nov 04
We Think You Should Be Aware Of Some Concerning Factors In Aker BioMarine's (OB:AKBM) Earnings

Aker BioMarine AS' (OB:AKBM) Has Found A Path To Profitability

Apr 13
Aker BioMarine AS' (OB:AKBM) Has Found A Path To Profitability

Aker BioMarine AS (OB:AKBM) Consensus Forecasts Have Become A Little Darker Since Its Latest Report

Feb 18
Aker BioMarine AS (OB:AKBM) Consensus Forecasts Have Become A Little Darker Since Its Latest Report

Loss-Making Aker BioMarine AS (OB:AKBM) Set To Breakeven

Jan 07
Loss-Making Aker BioMarine AS (OB:AKBM) Set To Breakeven

Análisis de la situación financiera

Pasivos a corto plazo: Los activos a corto plazo ($288.6M) de AKBM superan a sus pasivos a corto plazo ($113.5M).

Pasivo a largo plazo: Los activos a corto plazo de AKBM ($562.5M) superan a sus pasivos a largo plazo ($413.5M).


Historial y análisis de deuda-patrimonio

Nivel de deuda: La relación deuda neta-capital de AKBM (102.4%) se considera alta.

Reducción de la deuda: El ratio deuda-patrimonio de AKBM ha pasado de 149.5% a 111.4% en los últimos 5 años.


Hoja de balance


Análisis de cash runway

En el caso de las empresas que de media han sido deficitarias en el pasado, evaluamos si tienen al menos 1 año de cash runway.

Cash runway estable: Aunque no es rentable AKBM tiene suficiente cash runway para más de 3 años si mantiene su actual nivel positivo de flujo de caja libre.

Pronóstico de cash runway: AKBM no es rentable pero tiene suficiente cash runway para más de 3 años, debido a que el flujo de caja libre es positivo y crece un 24.9% al año.


Descubre empresas con salud financiera